Fibrinogen turnover and drugs acting on fibrinolysis.
D000368:Aged; D000605:Amino Alcohols / Q000008:administration & dosage / Q000627:therapeutic use; D062365:Aminobenzoates / Q000627:therapeutic use; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology* / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000188:drug therapy / Q000378:metabolism; D001777:Blood Coagulation / Q000187:drug effects; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism*; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006207:Half-Life; D006487:Hemostasis; D006490:Hemostatics / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D008744:Methylamines / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D010447:Peptide Hydrolases / Q000627:therapeutic use; D012911:Snakes; D013806:Theophylline / Q000008:administration & dosage / Q000627:therapeutic use; D014688:Venoms
D000605:Amino Alcohols; D062365:Aminobenzoates; D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids; D005343:Fibrinolytic Agents; D006490:Hemostatics; D008744:Methylamines; D009539:Nicotinic Acids; D014688:Venoms; D005340:Fibrinogen; D007611:Aprotinin; D013806:Theophylline; D010447:Peptide Hydrolases